NASDAQ:PETS - Petmed Express Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$23.59 +0.27 (+1.16 %)
(As of 02/17/2019 03:22 PM ET)
Previous Close$23.59
Today's Range$23.4001 - $23.9201
52-Week Range$20.25 - $48.32
Volume383,070 shs
Average Volume783,741 shs
Market Capitalization$487.70 million
P/E Ratio11.59
Dividend Yield4.63%
Beta0.55
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$273.80 million
Cash Flow$1.9273 per share
Book Value$6.43 per share

Profitability

Net Income$37.28 million

Miscellaneous

Employees187
Market Cap$487.70 million
OptionableOptionable

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Tuesday, January 22nd. Investors of record on Monday, February 4th will be given a dividend of $0.27 per share on Friday, February 15th. This represents a $1.08 dividend on an annualized basis and a yield of 4.58%. The ex-dividend date is Friday, February 1st. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) posted its quarterly earnings data on Tuesday, January, 22nd. The company reported $0.38 EPS for the quarter, missing the consensus estimate of $0.48 by $0.10. The business had revenue of $60.10 million for the quarter, compared to the consensus estimate of $64.22 million. Petmed Express had a return on equity of 32.89% and a net margin of 14.43%. The firm's quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.44 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, May 6th 2019. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

2 brokers have issued 1 year price objectives for Petmed Express' stock. Their predictions range from $18.00 to $18.00. On average, they expect Petmed Express' share price to reach $18.00 in the next twelve months. This suggests that the stock has a possible downside of 23.7%. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

Headlines about PETS stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Petmed Express earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.88%), Epoch Investment Partners Inc. (6.14%), Dimensional Fund Advisors LP (4.33%), LSV Asset Management (2.73%), River Road Asset Management LLC (2.29%) and Bank of New York Mellon Corp (2.10%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which major investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Penserra Capital Management LLC, Two Sigma Advisers LP, Millennium Management LLC, Gotham Asset Management LLC, Bank of America Corp DE, TD Asset Management Inc., Citigroup Inc. and Smith Asset Management Group LP. Company insiders that have sold Petmed Express company stock in the last year include Frank J Formica and Robert C Schweitzer. View Insider Buying and Selling for Petmed Express.

Which major investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including LSV Asset Management, River Road Asset Management LLC, Epoch Investment Partners Inc., Polaris Capital Management LLC, Bank of New York Mellon Corp, Profit Investment Management LLC, Virginia Retirement Systems ET AL and Copeland Capital Management LLC. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $23.59.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $487.70 million and generates $273.80 million in revenue each year. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  367 (Vote Underperform)
Total Votes:  508
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel